Zebra Medical appoints new CEO
January 22, 2020
KIBBUTZ SHEFAYIM, Israel – Zebra Medical Vision, the deep-learning medical imaging analytics company, announced that Ohad Arazi (pictured) has been appointed as chief executive officer, succeeding co-founder Eyal Gura, who will continue as chairman of the board.
Mr. Arazi brings to Zebra-Med extensive leadership experience in healthcare IT and medical imaging, along with a proven track record of driving transformative growth and building value at digital health firms, including McKesson Technology Solutions, Change Healthcare, and TELUS Health. Mr Arazi’s appointment is effective starting March 1, 2020.
“Ohad Arazi’s appointment is a clear reflection of the strong vector the Zebra Medical Vision team has created, as we’re ready to take on the future after another strong year of product innovation, unique regulatory progress, and customer successes,” says Gura. “Zebra-Med is poised for major expansion in the medical imaging domain, and we’re confident that Ohad’s unique experience in turning innovative technologies into scalable and impactful products will drive significant growth for us.”
“Every CEO dreams of being able to drive the evolution of a company from such a position of material strength. As we expand our footprint in North America, the breadth of Zebra-Med’s products and compelling regulatory advantage will allow us to scale extraordinarily fast,” says Ohad Arazi. “I’m thankful for the opportunity to lead one of the most exciting teams in healthcare today, and to leverage artificial intelligence to affect change for the medical imaging industry worldwide.”
With the 4th FDA clearance for its “all-in-one” AI1 bundle, Zebra-Med provides a one-stop-shop for health providers’ AI needs. From oncology and bone health, through cardiology and acute conditions alerts, to the ICU and ED units. In Q4 of 2019 the company also branched into the orthopaedic space with a partnership with DePuy Synthes.
About Zebra Medical Vision
Zebra Medical Vision’s Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease and offer improved, preventative treatment pathways to improve patient care. Zebra-Med is funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J, Dolby Ventures and leading AI researchers Prof Fei Fei Le, Prof Amnon Shashua and Richard Shocher. Zebra Medical Vision has raised $52 million in funding to date, and was named a Fast Company Top-5 AI and Machine Learning company. For more information, visit www.zebra-med.com.